COMMON STOCK PURCHASE WARRANT BRAINSTORM CELL THERAPEUTICS INC.Brainstorm Cell Therapeutics Inc. • August 14th, 2024 • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after _____, 20241 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _________20292 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
BRAINSTORM CELL THERAPEUTICS INC. AWARD AGREEMENT FOR RESTRICTED STOCK UNITS GRANTED UNDER SECTION 102(b)(2) OF THE ISRAELI INCOME TAX ORDINANCE TO EMPLOYEES, OFFICERS OR DIRECTORS AS 102 CAPITAL GAINS TRACK GRANTAward Agreement • August 14th, 2024 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances)
This Award Agreement (the “Agreement”) includes the Notice of Grant attached hereto as Exhibit A (the “Notice of Grant”), which is incorporated herein by reference and is made and entered into as of the Date of Grant shown in the Notice of Grant by and between Brainstorm Cell Therapeutics Inc. (the “Company”) and the Participant named in the Notice of Grant. Capitalized terms not defined in this Agreement shall have the meaning ascribed to them in the Plan.
BRAINSTORM CELL THERAPEUTICS INC. Restricted Stock Agreement Granted Under 2014 Stock Incentive PlanBrainstorm Cell Therapeutics Inc. • August 14th, 2024 • Biological products, (no disgnostic substances) • Delaware
Brainstorm Cell Therapeutics Inc. (the “Company”) has selected you to receive the restricted stock award described above, which is subject to the provisions of the Company’s 2014 Stock Incentive Plan (the “Plan”) and the terms and conditions contained in this Restricted Stock Agreement. Please confirm your acceptance of this restricted stock award and of the terms and conditions of this Agreement by signing a copy of this Agreement where indicated below.
June 19, 2024 Dr. Hartoun Hartounian Re: Employment Offer Dear Dr. HartounianBrainstorm Cell Therapeutics Inc. • August 14th, 2024 • Biological products, (no disgnostic substances)
April 16, 2024 PERSONAL AND CONFIDENTIAL Stacy Lindborg Re:Separation Agreement Dear Stacy:Personal and Confidential • August 14th, 2024 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
This letter confirms your separation from employment with Brainstorm Cell Therapeutics (the “Company”) effective as of May 9, 2024 (the “Separation Date”). This letter also proposes an agreement between you and the Company (the “Agreement”).
